Covid 19, Prostate Cancer, and VA

Researchers at the Department of Veterans Affairs and University of California-Los Angeles are studying whether a chemotherapy drug for prostate cancer can help reduce the severity of COVID-19 in men.
The VA announced last week that it will test degarelix, also known by its brand name Firmagon, in nearly 200 veterans hospitalized with the novel coronavirus at VA medical centers in Los Angeles, New York City and the Puget Sound area of Washington.
https://www.military.com/daily-news/2020/05/18/veterans-covid-19-will-be-given-prostate-cancer-drug-trial.html